Elanco executive granted deferred stock units

Elanco Animal Health Inc executive Rajeev A. Modi received a grant of deferred stock units as part of his compensation.

Rhea-AI Filing Summary

Elanco Animal Health Inc executive Rajeev A. Modi received a grant of deferred stock units as part of his compensation. On this award date, he acquired 64.7209 deferred stock units tied to Company common stock at a reference value of $22.82 per unit.

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. These units will settle in cash or shares after his employment ends or in a specified future year under the Company’s Executive Deferral and Stock Match Plan. Following this grant, Modi holds a total of 9,137.6387 deferred stock units directly.

Insider Trade Summary

Grant/Award: 64.7209 shares

Grant/Award 1 txn

Insider Modi Rajeev A.

Role SEE REMARKS

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	64.7209	$22.82	$1K

Holdings After Transaction: Deferred Stock Units — 9,137.6387 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred stock units granted: 64.7209 units Reference value per unit: $22.82 per unit Total deferred stock units after grant: 9,137.6387 units +1 more

4 metrics

Deferred stock units granted 64.7209 units Award on 2026-04-03 as compensation

Reference value per unit $22.82 per unit Grant value for deferred stock units

Total deferred stock units after grant 9,137.6387 units Direct holdings following the reported transaction

Conversion or exercise price $0.00 Deferred stock units settle for cash or shares

Key Terms

Deferred Stock Units, Executive Deferral and Stock Match Plan, Grant, award, or other acquisition, Common Stock

4 terms

Deferred Stock Units financial

"security_title: "Deferred Stock Units""

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Executive Deferral and Stock Match Plan financial

"in accordance with Executive Deferral and Stock Match Plan."

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Rajeev A. Modi report in this Elanco (ELAN) Form 4 filing?

Rajeev A. Modi reported receiving 64.7209 deferred stock units tied to Elanco common stock. These units were granted as compensation and increase his total deferred stock unit holdings to 9,137.6387, with settlement in cash or shares at a future date.

Is the Elanco (ELAN) Form 4 transaction a market buy or sell of shares?

The Form 4 shows a grant of deferred stock units, not an open-market purchase or sale. The transaction is coded as an acquisition award, reflecting compensation rather than trading activity, and therefore does not represent a discretionary buy or sell decision in the market.

How do Elanco (ELAN) deferred stock units work for Rajeev A. Modi?

Each deferred stock unit entitles Modi to receive either one Elanco common share or its cash equivalent. The units settle following termination of employment or in a specified future year, according to the company’s Executive Deferral and Stock Match Plan terms.

How many deferred stock units does Rajeev A. Modi hold after this Elanco (ELAN) grant?

After the grant, Modi directly holds 9,137.6387 deferred stock units. This figure includes the newly awarded 64.7209 units and represents his accumulated deferred compensation exposure linked to Elanco common stock or its cash equivalent under the company’s deferral plan.

What is the reference price for the new Elanco (ELAN) deferred stock units granted to Modi?

The newly granted 64.7209 deferred stock units carry a reference value of $22.82 per unit. While the units themselves have a conversion price of $0.00, this reference amount reflects the value used for the compensation award on the transaction date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/07/2026 - 05:19 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Modi Rajeev A.

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEE REMARKS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	04/03/2026		A		64.7209		(2)	(2)	Common Stock	64.7209	$22.82	9,137.6387	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Remarks:

Executive Vice President U.S. Pet Health and Global Digital Transformation

	/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)